http://web.archive.org/web/20150722095821id_/http://www.dailymail.co.uk/news/article-3022342/Drug-company-bullied-doctors-block-cheap-treatment-sight-loss.html

a drug company has been accused of trying to block trials aimed at promoting a ‘ cheap , safe and effective ’ treatment for sight loss on the @entity4			1
it has ‘ bullied ’ experts who have tried to prove that a cancer drug can be used to treat one of the most common forms of blindness , according to the @entity11			1
the respected medical journal says @entity13 is just as effective at tackling wet age - related macular degeneration ( @entity15 ) as the current treatment , @entity17			1
drug company @entity18 has been accused of trying to block trials aimed at promoting a ‘ cheap , safe and effective ’ treatment for sight loss which would save the @entity4 around £ 102million a year @entity13 is much cheaper and it is estimated that widespread use of the drug would save the @entity4 around £ 102million a year			1
but the @entity11 says the drug company has consistently tried to ‘ undermine and divert attention ’ from trials to prove @entity13 works – even turning to the @entity25 ( @entity25 ) for help			1
@entity15 is the most common form of blindness in people over 50			0
findings from clinical trials suggest @entity13 is safe and effective in treating @entity15 – but it costs £ 70 per treatment compared with £ 740 for an injection of @entity17			1
@entity18 , which markets @entity17 in the @entity33 , has allegedly tried to ‘ do everything ’ it can to stop trials of the cancer drug			2
the @entity11 obtained emails under a freedom of information request showing that clinicians with ties to @entity18 had urged some primary care trusts to pull out of one @entity13 trial , while efforts were made to ‘ derail ’ a second publicly funded @entity33 trial			2
the trial ’s chief investigator , @entity46 , a consultant ophthalmologist at @entity48 , @entity49 , told the @entity11 how , during the planning stage , a @entity18 representative tried to divert him to @entity18 funded work – with the prospect of future funds for personal research projects			0
the @entity11 says drug company @entity18 ( pictured ) has consistently tried to ‘ undermine and divert attention ’ from trials to prove @entity13 works – even turning to the @entity25 for help dr @entity46 said : ‘ he stated @entity18 would do everything to stop the trial and challenge its ethics			1
he stated the challenge would not come from @entity18 itself but from the @entity25			0
’ dr @entity46 said the @entity18 representative , whom he met in a pub , had funded an @entity25 campaign to get @entity17 made available to patients before approval by the @entity4 watchdog			2
@entity11 editor in chief , dr @entity71 , said the new evidence ‘ raises questions about the legal and regulatory positions that have skewed clinical practice , fuelled @entity4 drug costs , and left doctors confused about what they can and ca n’t prescribe ’			1
loss of vision that develops with age , known as age - related macular degeneration , is the most common cause of blindness in people over 50			1
most @entity15 starts as a ‘ dry ’ form but for one in five it progresses to the more severe , but treatable form of wet @entity15			0
@entity15 robs people of the central vision necessary for reading , driving or simply recognising people ’s faces			0
@entity15 is caused by abnormal growth of blood vessels around the eye			0
it can be treated by using drugs to stop the growth of a natural protein called vascular endothelial growth factor , which prevents the formation of new blood vessels			0
research suggests the number of @entity33 with @entity15 will rise by a quarter in the next decade , up from 600,000 at present to 750,000			0
she said : ‘ doctors and academics have carried out clinical trials despite threats and intimidation – and doctors leaders should follow suit and not allow themselves to be bullied either			2
‘ doctors ’ leaders also need to sort out the web of misinformation about drug prescribing that has been generated behind closed doors and is costing the @entity4 hundreds of millions of pounds a year by scaring doctors from using cheap and effective medicines			1
’ the @entity25 told the @entity11 that last year only 0.3 per cent of its total income was from drug companies			0
a spokesman said : ‘ we stand by our decision to challenge the trial , which was motivated entirely by our aim to protect patients ’ right to timely sight - saving treatment			2
’ a @entity18 spokesman said : ‘ @entity18 does not tolerate unethical behaviour by its associates in any country , and has a comprehensive compliance programme in place to help ensure that our associates comply with the company ’s code of conduct and all applicable laws			0
‘ @entity18 strongly believes that patients have the right to the highest standard of care and that this right should be defended to promote safety and quality			0

drug company accused of trying to block trials aimed at promoting a ' cheap , safe and effective ' treatment for sight loss on the @entity4
it ' bullied ' experts who tried to prove drug can be used to treat blindness
@entity13 is effective at tackling wet age - related macular degeneration
cheaper than the current treatment it would save @entity4 £ 102million a year

@entity17:Lucentis
@entity15:AMD
@entity13:Avastin
@entity11:BMJ
@entity4:NHS
@entity48:Queen ’s Medical Centre
@entity25:RNIB
@entity33:Britons
@entity18:Novartis
@entity46:Foss
@entity71:Fiona Godlee
@entity49:Nottingham